Query         gi|254781125|ref|YP_003065538.1| hypothetical protein CLIBASIA_05135 [Candidatus Liberibacter asiaticus str. psy62]
Match_columns 59
No_of_seqs    1 out of 3
Neff          1.0 
Searched_HMMs 39220
Date          Mon May 30 05:10:56 2011
Command       /home/congqian_1/programs/hhpred/hhsearch -i 254781125.hhm -d /home/congqian_1/database/cdd/Cdd.hhm 

 No Hit                             Prob E-value P-value  Score    SS Cols Query HMM  Template HMM
  1 pfam05418 Apo-VLDL-II Apovitel  21.8      43  0.0011   16.7   1.1   25   22-46      6-30  (82)
  2 KOG0676 consensus               18.7      54  0.0014   16.1   1.1   47    2-48     82-132 (372)
  3 pfam07982 Herpes_UL74 Herpes U  18.7      14 0.00035   19.4  -2.0   36   10-45    344-379 (457)
  4 COG1096 Predicted RNA-binding   18.2      76  0.0019   15.3   1.8   17   15-31    134-150 (188)
  5 pfam10876 DUF2669 Protein of u  16.1      41  0.0011   16.8   0.0   25    4-28     67-94  (133)
  6 CHL00004 psbD photosystem II p  14.1      27 0.00069   17.8  -1.4   24   12-35    323-347 (353)
  7 TIGR01793 cit_synth_euk citrat  12.5   1E+02  0.0027   14.6   1.2   24   30-53    114-138 (430)
  8 cd01730 LSm3 The eukaryotic Sm  11.4 1.4E+02  0.0035   13.9   1.5   18   17-34     26-43  (82)
  9 COG1973 HypE Hydrogenase matur  11.1 1.5E+02  0.0039   13.6   1.8   26   34-59    261-286 (449)
 10 PRK10141 DNA-binding transcrip  11.1      62  0.0016   15.8  -0.3   18    1-19      2-19  (106)

No 1  
>pfam05418 Apo-VLDL-II Apovitellenin I (Apo-VLDL-II). This family consists of several avian apovitellenin I sequences. As part of the avian reproductive effort, large quantities of triglyceride-rich very-low-density lipoprotein (VLDL) particles are transported by receptor-mediated endocytosis into the female germ cells. Although the oocytes are surrounded by a layer of granulosa cells harbouring high levels of active lipoprotein lipase, non-lipolysed VLDL is transported into the yolk. This is because VLDL particles from laying chickens are protected from lipolysis by apolipoprotein (apo)-VLDL-II, a potent dimeric lipoprotein lipase inhibitor. Apo-VLDL-II is produced in the liver and secreted into the blood stream when induced by estrogen production in female birds.
Probab=21.81  E-value=43  Score=16.68  Aligned_cols=25  Identities=28%  Similarity=0.514  Sum_probs=16.9

Q ss_pred             CCCCEEEEEECCCHHHHHHHHCCCH
Q ss_conf             5875037871114377898616871
Q gi|254781125|r   22 KDPHYNVIFRDEVPSFIYETLNIPA   46 (59)
Q Consensus        22 kdphynvifrdevpsfiyetlnipa   46 (59)
                      +|-.--...-|.+.++|||+.|--.
T Consensus         6 rdRRdwlviPda~AaYiYEaVNk~s   30 (82)
T pfam05418         6 RDRRDWLVIPDAVAAYIYEAVNKMS   30 (82)
T ss_pred             CCCCCEEECHHHHHHHHHHHHHHCC
T ss_conf             3543313340899999999987028


No 2  
>KOG0676 consensus
Probab=18.67  E-value=54  Score=16.14  Aligned_cols=47  Identities=23%  Similarity=0.360  Sum_probs=30.9

Q ss_pred             CHHHHHHH---HCCCCCEEEEECCCCCEEE-EEECCCHHHHHHHHCCCHHH
Q ss_conf             24899998---5078641473025875037-87111437789861687113
Q gi|254781125|r    2 SPILEYIR---CLNDPNRYRLSAKDPHYNV-IFRDEVPSFIYETLNIPADK   48 (59)
Q Consensus         2 spileyir---clndpnryrlsakdphynv-ifrdevpsfiyetlnipadk   48 (59)
                      ..|..|+.   -..+|+-..+..-+|.+|- -.|...-.+.+||+|+||=-
T Consensus        82 e~iw~~if~~~L~~~Pee~pvllte~pl~p~~nREk~tqi~FE~fnvpa~y  132 (372)
T KOG0676          82 EKIWHHLFYSELLVAPEEHPVLLTEPPLNPKANREKLTQIMFETFNVPALY  132 (372)
T ss_pred             HHHHHHHHHHHHCCCCCCCCEEEECCCCCCHHHHHHHHHHHHHHCCCCHHH
T ss_conf             999999998764238664864754378883576888887755436863658


No 3  
>pfam07982 Herpes_UL74 Herpes UL74 glycoproteins. Members of this family are viral glycoproteins that form part of an envelope complex.
Probab=18.66  E-value=14  Score=19.40  Aligned_cols=36  Identities=36%  Similarity=0.553  Sum_probs=26.8

Q ss_pred             HCCCCCEEEEECCCCCEEEEEECCCHHHHHHHHCCC
Q ss_conf             507864147302587503787111437789861687
Q gi|254781125|r   10 CLNDPNRYRLSAKDPHYNVIFRDEVPSFIYETLNIP   45 (59)
Q Consensus        10 clndpnryrlsakdphynvifrdevpsfiyetlnip   45 (59)
                      |-.+-||-..|.---+-.|..|.|.|.-||.||+..
T Consensus       344 C~~~RNrTAvSefmknThvlirNeTPyTIYGTLdms  379 (457)
T pfam07982       344 CKPDRNRTAVSEFMKNTHVLIRNETPYTIYGTLDMS  379 (457)
T ss_pred             CCCCCCHHHHHHHHHCCEEEEECCCCEEEEEEECCH
T ss_conf             686544478999863236887358870478751010


No 4  
>COG1096 Predicted RNA-binding protein (consists of S1 domain and a Zn-ribbon domain) [Translation, ribosomal structure and biogenesis]
Probab=18.24  E-value=76  Score=15.34  Aligned_cols=17  Identities=29%  Similarity=0.471  Sum_probs=15.0

Q ss_pred             CEEEEECCCCCEEEEEE
Q ss_conf             41473025875037871
Q gi|254781125|r   15 NRYRLSAKDPHYNVIFR   31 (59)
Q Consensus        15 nryrlsakdphynvifr   31 (59)
                      ..++||.+.++|.|||-
T Consensus       134 ~~~~Lst~~~dlGVI~A  150 (188)
T COG1096         134 DPIQLSTKGNDLGVIYA  150 (188)
T ss_pred             CCEEEEECCCCCEEEEE
T ss_conf             87189852786169999


No 5  
>pfam10876 DUF2669 Protein of unknown function (DUF2669). This family of proteins has no known function.
Probab=16.13  E-value=41  Score=16.76  Aligned_cols=25  Identities=36%  Similarity=0.680  Sum_probs=19.4

Q ss_pred             HHHHHHHC-CCCCEEEEEC--CCCCEEE
Q ss_conf             89999850-7864147302--5875037
Q gi|254781125|r    4 ILEYIRCL-NDPNRYRLSA--KDPHYNV   28 (59)
Q Consensus         4 ileyircl-ndpnryrlsa--kdphynv   28 (59)
                      ||++.-|- +|-|.||||.  -+.|+|.
T Consensus        67 Vlk~t~~~~~dG~~yrLs~d~Fn~HFNt   94 (133)
T pfam10876        67 VLKHTSCEGQDGKTYRLSPDRFNQHFNT   94 (133)
T ss_pred             HHHHHEEECCCCCEEEECHHHHHHHHHH
T ss_conf             9887316658995798378898889888


No 6  
>CHL00004 psbD photosystem II protein D2
Probab=14.09  E-value=27  Score=17.77  Aligned_cols=24  Identities=42%  Similarity=0.635  Sum_probs=15.4

Q ss_pred             CCCCEEEEECC-CCCEEEEEECCCH
Q ss_conf             78641473025-8750378711143
Q gi|254781125|r   12 NDPNRYRLSAK-DPHYNVIFRDEVP   35 (59)
Q Consensus        12 ndpnryrlsak-dphynvifrdevp   35 (59)
                      |+--|-..++. .||-|.+|..||-
T Consensus       323 neg~r~wm~~~dqphen~~f~eevl  347 (353)
T CHL00004        323 NEGIRAWMAAQDQPHENLIFPEEVL  347 (353)
T ss_pred             HHHHHHHHCCCCCCCCCCCCCHHHC
T ss_conf             7778887402358753456726646


No 7  
>TIGR01793 cit_synth_euk citrate (Si)-synthase, eukaryotic; InterPro: IPR010109   Citrate synthase 2.3.3.1 from EC is a member of a small family of enzymes that can directly form a carbon-carbon bond without the presence of metal ion cofactors. It catalyses the first reaction in the Krebs' cycle, namely the conversion of oxaloacetate and acetyl-coenzyme A into citrate and coenzyme A. This reaction is important for energy generation and for carbon assimilation. The reaction proceeds via a non-covalently bound citryl-coenzyme A intermediate in a 2-step process (aldol-Claisen condensation followed by the hydrolysis of citryl-CoA).    Citrate synthase enzymes are found in two distinct structural types: type I enzymes (found in eukaryotes, Gram-positive bacteria and archaea) form homodimers and have shorter sequences than type II enzymes, which are found in Gram-negative bacteria and are hexameric in structure. In both types, the monomer is composed of two domains: a large alpha-helical domain consisting of two structural repeats, where the second repeat is interrupted by a small alpha-helical domain. The cleft between these domains forms the active site, where both citrate and acetyl-coenzyme A bind. The enzyme undergoes a conformational change upon binding of the oxaloacetate ligand, whereby the active site cleft closes over in order to form the acetyl-CoA binding site . The energy required for domain closure comes from the interaction of the enzyme with the substrate. Type II enzymes possess an extra N-terminal beta-sheet domain, and some type II enzymes are allosterically inhibited by NADH .   This entry includes both mitochondrial and peroxisomal forms of citrate synthase. Peroxisomal forms of the enzyme, recognized by the C-terminal targeting motif SKL, act in the glyoxylate cycle. Eukaryotic homologs include a Tetrahymena thermophila citrate synthase that doubles as a filament protein, a putative citrate synthase from Plasmodium falciparum (no TCA cycle), and a methylcitrate synthase from Aspergillus nidulans (Emericella nidulans).; GO: 0004108 citrate (Si)-synthase activity, 0044262 cellular carbohydrate metabolic process.
Probab=12.54  E-value=1e+02  Score=14.58  Aligned_cols=24  Identities=21%  Similarity=0.462  Sum_probs=17.8

Q ss_pred             EECCCHHHHHHHH-CCCHHHHHHHH
Q ss_conf             7111437789861-68711346888
Q gi|254781125|r   30 FRDEVPSFIYETL-NIPADKRKMAV   53 (59)
Q Consensus        30 frdevpsfiyetl-nipadkrkmav   53 (59)
                      -|-.+|.||++++ ++|..-.-||-
T Consensus       114 aRadlP~hv~~~iD~~P~tlHPMaQ  138 (430)
T TIGR01793       114 ARADLPKHVVKLIDALPSTLHPMAQ  138 (430)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCHHHH
T ss_conf             5500278999998505743572789


No 8  
>cd01730 LSm3 The eukaryotic Sm and Sm-like (LSm) proteins associate with RNA to form the core domain of the ribonucleoprotein particles involved in a variety of RNA processing events including pre-mRNA splicing, telomere replication, and mRNA degradation.  Members of this family share a highly conserved Sm fold containing an N-terminal helix followed by a strongly bent five-stranded antiparallel beta-sheet. LSm3 is one of at least seven subunits that assemble onto U6 snRNA to form a seven-membered ring structure.  Sm-like proteins exist in archaea as well as prokaryotes that form heptameric and hexameric ring structures similar to those found in eukaryotes.
Probab=11.41  E-value=1.4e+02  Score=13.94  Aligned_cols=18  Identities=44%  Similarity=0.493  Sum_probs=14.4

Q ss_pred             EEEECCCCCEEEEEECCC
Q ss_conf             473025875037871114
Q gi|254781125|r   17 YRLSAKDPHYNVIFRDEV   34 (59)
Q Consensus        17 yrlsakdphynvifrdev   34 (59)
                      -+|-|-|.|+|.+..|-.
T Consensus        26 G~L~afD~h~NlVL~d~e   43 (82)
T cd01730          26 GRLHAYDQHLNMILGDVE   43 (82)
T ss_pred             EEEEEECCEEEEEEECCE
T ss_conf             999973402268851639


No 9  
>COG1973 HypE Hydrogenase maturation factor [Posttranslational modification, protein turnover, chaperones]
Probab=11.14  E-value=1.5e+02  Score=13.64  Aligned_cols=26  Identities=31%  Similarity=0.351  Sum_probs=18.2

Q ss_pred             CHHHHHHHHCCCHHHHHHHHHHHHHC
Q ss_conf             43778986168711346888887519
Q gi|254781125|r   34 VPSFIYETLNIPADKRKMAVIRSYML   59 (59)
Q Consensus        34 vpsfiyetlnipadkrkmavirsyml   59 (59)
                      .+..++||||+---+.--|.+||+.+
T Consensus       261 m~DVv~ETlnv~fi~a~eai~~s~L~  286 (449)
T COG1973         261 MHDVVEETLNVDFIRACEAIVRSGLL  286 (449)
T ss_pred             CHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_conf             27888876274899999999985056


No 10 
>PRK10141 DNA-binding transcriptional repressor ArsR; Provisional
Probab=11.13  E-value=62  Score=15.80  Aligned_cols=18  Identities=22%  Similarity=0.650  Sum_probs=13.7

Q ss_pred             CCHHHHHHHHCCCCCEEEE
Q ss_conf             9248999985078641473
Q gi|254781125|r    1 MSPILEYIRCLNDPNRYRL   19 (59)
Q Consensus         1 mspileyirclndpnryrl   19 (59)
                      |+|+ +..++|.||+|.+.
T Consensus         2 ~~~v-~lFkaLaD~tRl~I   19 (106)
T PRK10141          2 LTPL-QLFKILSDETRLGI   19 (106)
T ss_pred             CCHH-HHHHHHCCHHHHHH
T ss_conf             9889-99999088999999


Done!